Frédéric Collin
Impact in
- Toxicology top 1%
- Bioactive Compounds and Antitumor Agents
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Cancer therapeutics and mechanisms 7
- DNA and Nucleic Acid Chemistry 1
- Genomics, phytochemicals, and oxidative stress 1
-
- Bioactive Compounds and Antitumor Agents 3
- Co-authors
- Anthony Maxwell (7 shared papers)Shantanu Karkare (2 shared papers)Richard J. Payne (2 shared papers)Robert E. Thompson (2 shared papers)Katrina A. Jolliffe (2 shared papers)Adam R. McKay (1 shared paper)Lesley A. Mitchenall (1 shared paper)J.J.M. Meyer (1 shared paper)
- Journals
- Journal of Molecular Biology (2 papers)Organic & Biomolecular Chemistry (1 paper)Tuberculosis (1 paper)Applied Microbiology and Biotechnology (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- United KingdomAustraliaHungary
In The Last Decade
Frédéric Collin
9 papers receiving 709 citations
Peers
Comparison fields: 5 of 74
- Toxicology 124
- Molecular Medicine 136
- Microbiology 48
- Biological Psychiatry 17
- Molecular Biology 468
Countries citing papers authored by Frédéric Collin
This map shows the geographic impact of Frédéric Collin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Collin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Collin more than expected).
Fields of papers citing papers by Frédéric Collin
This network shows the impact of papers produced by Frédéric Collin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Collin. The network helps show where Frédéric Collin may publish in the future.
Co-authors
The 25 scholars most cited alongside Frédéric Collin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 448 | |
| 2 | 2018 | 86 | |
| 3 | 2012 | 65 | |
| 4 | 2019 | 52 | |
| 5 | 2015 | 26 | |
| 6 | 2013 | 26 | |
| 7 | 2014 | 12 | |
| 8 | 1993 | 6 | |
| 9 | 2020 | 4 |
About Frédéric Collin
Frédéric Collin is a scholar working on Molecular Biology, Toxicology, Infectious Diseases, Pharmacology and Molecular Medicine, having authored 9 papers that have together received 725 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (7 papers), Bioactive Compounds and Antitumor Agents (3 papers), Antibiotic Resistance in Bacteria (2 papers), Tuberculosis Research and Epidemiology (1 paper), DNA and Nucleic Acid Chemistry (1 paper), Toxin Mechanisms and Immunotoxins (1 paper), Genomics, phytochemicals, and oxidative stress (1 paper) and Antimicrobial Resistance in Staphylococcus (1 paper). The work is most often cited by research in Toxicology (124 citations), Molecular Medicine (136 citations), Microbiology (48 citations), Biological Psychiatry (17 citations) and Molecular Biology (468 citations). Frédéric Collin has collaborated with scholars based in United Kingdom, Australia and Hungary. Frequent co-authors include Anthony Maxwell, Shantanu Karkare, Richard J. Payne, Robert E. Thompson, Katrina A. Jolliffe, Adam R. McKay, Lesley A. Mitchenall, J.J.M. Meyer, Sandra J. Greive and Namrita Lall. Their work appears in journals such as Journal of Molecular Biology, Organic & Biomolecular Chemistry, Tuberculosis, Applied Microbiology and Biotechnology and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.